Jacobus – Recall of Ruzurgi® (amifampridine)
September 13, 2021 - Jacobus announced a voluntary, consumer level recall of three lots of Ruzurgi (amifampridine) because the tablets have been found to be contaminated with yeast, mold, and aerobic bacteria based on laboratory test results.
Download PDF
